Compare HALO & STWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | STWD |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.4B |
| IPO Year | N/A | 2009 |
| Metric | HALO | STWD |
|---|---|---|
| Price | $68.77 | $18.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $73.33 | $20.63 |
| AVG Volume (30 Days) | 2.3M | ★ 3.0M |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 10.36% |
| EPS Growth | ★ 56.68 | N/A |
| EPS | ★ 4.74 | 1.04 |
| Revenue | ★ $1,242,852,000.00 | $490,651,000.00 |
| Revenue This Year | $34.83 | $366.38 |
| Revenue Next Year | $24.84 | $12.15 |
| P/E Ratio | ★ $14.54 | $17.81 |
| Revenue Growth | ★ 31.19 | 12.42 |
| 52 Week Low | $47.00 | $16.59 |
| 52 Week High | $79.50 | $21.05 |
| Indicator | HALO | STWD |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 54.14 |
| Support Level | $61.23 | $18.40 |
| Resistance Level | $69.28 | $18.65 |
| Average True Range (ATR) | 1.69 | 0.22 |
| MACD | 0.69 | 0.02 |
| Stochastic Oscillator | 93.54 | 71.57 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment, and Investing & Servicing Segment. The company generates the majority of its revenue from the Commercial and Residential Lending Segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.